Annals of internal medicine
-
Randomized Controlled Trial Multicenter Study
Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.
Dapagliflozin, a selective inhibitor of sodium-glucose cotransporter 2, may improve glycemic control with a lower dose of insulin and attenuate the associated weight gain in patients with inadequate control despite high doses of insulin. ⋯ AstraZeneca and Bristol-Myers Squibb.
-
Randomized Controlled Trial Comparative Study
Peer mentoring and financial incentives to improve glucose control in African American veterans: a randomized trial.
Compared with white persons, African Americans have a greater incidence of diabetes, decreased control, and higher rates of microvascular complications. A peer mentorship model could be a scalable approach to improving control in this population and reducing disparities in diabetic outcomes. ⋯ National Institute on Aging Roybal Center.